Lentiviral gene therapy with platelet-derived growth factor B sustains accelerated healing of diabetic wounds over time

Annals of Plastic Surgery

Volumn 55, Issue 1, 2005, Pages 81-86

  Man, Li Xing ^a,c   Park, Juliet C ^a   Terry, Michael J ^a   Mason, James M ^b   Burrell, Whitney A ^a   Liu, Fangjun ^a   Kimball, Brent Y ^a   Moorji, Sameer M ^b   Lee, James A ^a   Breitbart, Arnold S ^a,d   Hutchinson, Olivia ^d  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d NONE

Author keywords

Diabetic wound; Lentiviral gene therapy; PDGF

Indexed keywords

LENTIVIRUS VECTOR; PLATELET DERIVED GROWTH FACTOR B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STAINING; VIRAL GENE THERAPY; WOUND; WOUND HEALING;

ANALYSIS OF VARIANCE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOENZYME TECHNIQUES; LENTIVIRUS; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-SIS; STAINING AND LABELING; WOUND HEALING;

EID: 21244435687     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sap.0000168211.76318.fa     Document Type: Article

References (45)

1. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382-387.
2. Stockl K, Vanderplas A, Tafesse E, et al. Costs of lower-extremity ulcers among patients with diabetes. Diabetes Care. 2004;27:2129-2134.
3. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217-228.
4. Greenhalgh DG, Sprugel KH, Murray MJ, et al. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol. 1990;136:1235-1246.
5. Brown RL, Breeden MP, Greenhalgh DG. PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse. J Surg Res. 1994;56:562-570.
6. Altavilla D, Saitta A, Cucinotta D, et al. Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes. 2001;50:667-674.
7. Greenhalgh DG. Wound healing and diabetes mellitus. Clin Plast Surg. 2003;30:37-45.
8. Pierce GF, Mustoe TA. Pharmacologic enhancement of wound healing. Annu Rev Med. 1995;46:467-481.
9. Pierce GF, Mustoe TA, Altrock BW, et al. Role of platelet-derived growth factor in wound healing. J Cell Biochem. 1991;45:319-326.
10. Pierce GF, Tarpley JE, Yanagihara D. et al. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing: neovessel and matrix formation and cessation of repair. Am J Pathol. 1992;140:1375-1388.
11. Grotendorst GR, Martin GR, Pencev D, et al. Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest. 1985;76:2323-2329.
12. Mustoe TA, Pierce GF, Morishima C. et al. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest. 1991;87:694-703.
13. Albertson S, Hummel RP 3rd, Breeden M, et al. PDGF and FGF reverse the healing impairment in protein-malnourished diabetic mice. Surgery. 1993;114:368-372.
14. Karr BP, Bubak PJ, Sprugel KH, et al. Platelet-derived growth factor and wound contraction in the rat. J Surg Res. 1995;59:739-742.
15. Mustoe TA, Purdy J, Gramates P, et al. Reversal of impaired wound healing in irradiated rats by platelet-derived growth factor-BB. Am J Surg. 1989;158:345-350.
16. Saba AA, Freedman BM, Gaffield JW, et al. Topical platelet-derived growth factor enhances wound closure in the absence of wound contraction: an experimental and clinical study. Ann Plast Surg. 2002;49: 62-66.
17. Wieman TJ. Clinical efficacy of becaplermin (rhPDGF-BB) gel: Becaplermin Gel Studies Group. Am J Surg. 1998;176(2A suppl):74S-79S.
18. Robson MC, Phillips LG, Thomason A, et al. Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Ann Plast Surg. 1992;29:193-201.
19. Robson MC, Phillips LG, Thomason A, et al. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet. 1992; 339:23-25.
20. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers: Diabetic Ulcer Study Group. J Vasc Surg. 1995;21:71-78.
21. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study. Diabetes Care. 1998;21:822-827.
22. Kantor J, Margolis DJ. Treatment options for diabetic neuropathic foot ulcers: a cost-effectiveness analysis. Dermatol Surg. 2001;27:347-351.
23. Cupp CL, Bloom DC. Gene therapy, electroporation, and the future of wound-healing therapies. Facial Plast Surg. 2002;18:53-57.
24. Goldman R. Growth factors and chronic wound healing: past, present, and future. Adv Skin Wound Care. 2004;17:24-35.
25. Breitbart AS, Mason JM, Urmacher C, et al. Gene-enhanced tissue engineering: applications for wound healing using cultured dermal fibroblasts transduced retrovirally with the PDGF-B gene. Ann Plast Surg. 1999;43:632-639.
26. Breitbart AS, Grande DA, Laser J, et al. Treatment of ischemic wounds using cultured dermal fibroblasts transduced retrovirally with PDGF-B and VEGF121 genes. Ann Plant Surg. 2001;46:555-561.
27. Breitbart AS, Laser J. Parrett B, et al. Accelerated diabetic wound healing using cultured dermal fibroblasts retrovirally transduced with the platelet-derived growth factor B gene. Ann Plast Surg. 2003;51:409-414.
28. Lever AM, Strappe PM, Zhao J. Lentiviral vectors. J Biomed Sci. 2004;11:439-449.
29. Kordower JH, Emborg ME, Bloch J, et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science. 2000;290:767-773.
30. Lee JA, Conejero JA, Mason JM, et al. Lentiviral transfection with the PDGF-B gene improves diabetic wound healing. Plast Recon Surg. In press.
31. Klages N, Zufferey R, Trono D. A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol Ther. 2000;2: 170-176.
32. Montes GS, Junqueira LC. The use of the Picrosirius-polarization method for the study of the biopathology of collagen. Mem Inst Oswalde Cruz. 1991;86(suppl 3):1-11.
33. Sanders JE.,Goldstein BS, Leotta DF, et al. Image processing techniques for quantitative analysis of skin structures. Comput Methods Programs Biomed. 1999;59:167-180.
34. Coleman DL. Diabetes-obesity syndromes in mice. Diabetes. 1982; 31(suppl 1 pt 2):1-6.
35. Greenhalgh DG, Hummel RP 3rd, Albertson S, et al. Synergistic actions of platelet-derived growth factor and the insulin-like growth factors in vivo. Wound Repair Regen. 1993;1:69-81.
36. Kampfer H, Pfeilschifter J, Frank S. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest. 2001;81:361-373.
37. Wetzler C, Kampfer H, Stallmeyer B, et al. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol. 2000;115: 245-253.
38. Chleboun JO, Martins R, Rao S. Laser Doppler velocimetry and platelet-derived growth factor as prognostic indicators for the healing of ulcers and ischaemic lesions of the lower limb. Cardiovasc Surg. 1995;3:285-290.
39. Pierce GF, Tarpley JE, Tseng J, et al. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest. 1995;96:1336-1:350.
40. McLachlin JR, Cornetta K, Eglitis MA. et al. Retroviral-mediated gene transfer. Prog Nucleic Acid Res Mol Biol. 1990;38:91-135.
41. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Bio techniques 1989;7:980-982; 984-986, 989-990.
42. Keswani SG, Katz AB, Lim FY, et al. Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds. Wound Repair Regen. 2004;12:497-504.
43. Gu DL. Nguyen T, Gonzalez AM, et al. Adenovirus encoding human platelet-derived growth factor-B delivered in collagen exhibits safety, biodistribution, and immunogenicity profiles favorable for clinical use. Mol Ther. 2004;9:699-711.
44. Quantin B, Perricaudet LD, Tajbakhsh S, et al. Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA. 1992;89:2581-2584.
45. Cao H, Koehler DR, Hu J. Adenoviral vectors for gene replacement therapy. Virol Immunol. 2004;17:327-333.